October 2026 Issue
Volume 5 Issue 8
In this issue, we explore the remaining challenges in bringing microarray patches to market, examine the role of technology transfer, quality systems, and organizational readiness in vaccine scale-up, and learn how data-driven targeting could support immunization outreach to zero-dose children.
“Vaccine scale-up failure is not a story of bad science. It is a story of systemic unreadiness.” – Thirunavukkarasu Angappan, VP, Operations & Manufacturing, PopVax
“Acknowledging the necessity of outreach does not mean accepting its historical inefficiencies.” – Wendy Prosser, Senior Technical Officer, JSI
